Background: Lidocaine is commonly used for rapid sequence intubation (RSI) in emergency departments. Its benefits remain controversial. Traditional regression methods are commonly used to draw causal inferences. Propensity score matching based method, could be the solution for studies with limited sample size. Aim: To re-examine the association between postintubation hypotension (PIH) and lidocaine injection using different analysis methods. Materials and methods: Secondary analysis was conducted of a retrospective cohort study with patients in emergency departments undergoing RSI. Clinical information was recorded. PIH was defined as postintubation systolic blood pressure of <90 mmHg. Based on the propensity score of having lidocaine injection generated by several variables, matching methods were applied and a comparable control group generated. Outcome models based on logistic regression were compared using the original and matched datasets. Results: Among 149 patients who received RSI agents, 28 developed PIH. Among 120 who received lidocaine injection, 27 developed PIH, as did one the 29 patients who did not receive lidocaine. Lidocaine was not significantly associated with PIH in the traditional regression model adjusting preintubation systolic blood pressure 140 mmHg, underlying history of chronic obstructive pulmonary disease, ongoing septic status, and body weight. After 1:5 nearest matching with replacement based on the propensity score, most measurable potential confounders were comparable in lidocaine-treated and control groups, except ongoing heart disease (e.g., atrial fibrillation and coronary artery disease). In the subsequent logistic regression model adjusted for ongoing heart disease in the matched dataset, lidocaine was significantly associated with PIH. Conclusion: Lidocaine injection could be associated with PIH; however, further investigation is needed. Alternative statistical methods should be considered when making a causal inference.
Introduction
Many patients with airway compromise admitted to emergency departments are difficult to manage because they are either uncooperative or in an unrestrained position. Therefore, development of a safe and rapid method to achieve airway control is critical for improving the prognosis of these patients. 1 Rapid sequence intubation (RSI) has high success rate 2e9 and airway control is achieved faster in patients when RSI is used. Furthermore, RSI reduces the complications of intubation, such as aspiration, hypoxemia, laryngospasm, and bronchospasm, and prevents further cervical injury. Some immediate complications after RSI include hypoxemia, transient decrease in systolic blood pressure, arrhythmia, and even death 3e5,7,8 but few studies 10, 11 have reported adverse outcomes after RSI.
Lidocaine is a prerequisite premedication agent during RSI for attenuating airway reaction and resistance, 12, 13 reducing cough reflex and preventing increase in intracranial pressure (ICP) in the case of head injury. 14, 15 Although some studies have reported 16 that lidocaine reduced secondary brain injury by decreasing cerebral flow, cerebral vascular resistance, and cerebral metabolism, and by stabilizing neuronal membranes by acting as a sodium channel blocker, other studies indicate 17, 18 that lidocaine increases heart rate and blood pressure, decreases the mean arterial pressure, and decreases perfusion pressure leading to poor neurological outcome in cases of acute stroke. The advantages and disadvantages of lidocaine are still controversial. 19 In a previous study, 11 we identified four independent risk factors of hypotension after RSI using the traditional regression method, but administration of lidocaine failed to achieve statistical significance.
In this study, we re-examined the causal relationship between lidocaine administration and postintubation hypotension (PIH) using a case-control study. We also compared the traditional regression methods with a propensity score matching based method for causal inference. The latter method might have an advantage in evaluating the effects of treatments on health outcomes and other clinical research using observational data with limited sample size.
Materials and methods

Study design and setting
This is a secondary data analysis of a caseecontrol study. The data obtained between March 2002 and September 2002 from all adult nontrauma patients who received RSI in the emergency department of a tertiary 3700-bed medical center were retrospectively analyzed. This study was approved by the Ethics Committee on Human Research of the hospital and was exempt from the requirement of obtaining informed consent under agreement.
Patient selection and data collection
Inclusion criteria for selection of patients were patients older than 18 years who were seen in the emergency department requiring emergency airway management and who underwent RSI during the study period. The exclusion criteria included initial systolic blood pressure < 90 mmHg, apparent shock, ventricular arrhythmia, trauma as cause of injury, receipt of fluid resuscitation and inotropic agents, cardiac arrest, hypoxemia (pulse oximetry reading, < 90%), esophageal intubation, tube malposition, and more than three attempts at intubation. Standardized RSI includes preparation, preoxygenation, pretreatment, paralysis with induction, placement of the tube, and postintubation management. The most common pretreatment medications used during RSI were lidocaine (1e1.5 mg/ kg), midazolam (0.05e0.1 mg/kg), ketamine (1e2 mg/kg), and rocuronium (0.8e1.2 mg/kg).
The included patients were first divided into two groups; the hypotension group and the normal control group. Hypotension was defined as pre-RSI systolic blood pressure < 90 mmHg no earlier than 5 minutes prior to intubation. The data were collected in four categories: (1) basic anthropometrics, including age, sex, body weight, underlying diagnosis, and ongoing disease; (2) vital signs prior to and after RSI, including heart rate and blood pressure; (3) blood biochemistry, including white blood cell count, levels of hemoglobin, sodium, potassium, albumin, creatinine, and arterial blood gas; and (4) drugs administered during RSI, including their dose. Next, the patients were reclassified into "patients with lidocaine" and "patients without lidocaine" for sequential propensity score matching. The relationship between lidocaine administration and postintubation hypotension was analyzed.
Statistical analysis
Biostatistical analysis was performed using Chi-square test or Fisher's test for categorical variables and Student t test of Wilcoxon rank-sum test for continuous variables. A p value <0.05 was considered statically significant. Univariate analysis and multiple logistic regression analysis were used to analyze the factors influencing the occurrence of hypotension after RSI. Adjustment for confounding variables was performed using two methods: traditional logistic regression method; and propensity score matching based method, which used the available variables to predict whether patients receiving lidocaine had similar propensity scores. To reduce treatment selection bias for RSI and any other related potential confounding variable, the baseline characteristics of the patient were adjusted using propensity scores. The propensity scores for receiving lidocaine as one of the pretreatment medications were estimated using multiple logistic regression analysis, including the following variables: age, sex, body weight, vital signs prior to intubation (i.e., oxygen saturation, pulse rate, respiratory rate, and blood pressure), underlying illness (i.e., diabetes, hypertension, stroke, chronic obstructive pulmonary disease, lung cancer, coronary artery disease, and chronic kidney disease), and ongoing disease, including sepsis, trauma, chronic obstructive pulmonary disease (COPD) with acute exacerbation, old stroke [old cerebrovascular accident (CVA)], diabetes mellitus (DM), hypertension (HTN), renal disease, cancer, and heart disease. Ongoing diseases included COPD, sepsis, congestive heart failure (CHF), CVA, acute myocardial infarction (AMI), liver disease, pneumonia, renal disease, seizure disorder, upper gastrointestinal tract bleeding (UGIB), intoxication, and malignancy. The Akaike information criterion (AIC) was also used.
Results
Of the 149 patients from whom data was collected, 28 patients developed PIH. The majority in both the PIH and control groups were male, and the average age was 72 years. The body weight of patients in the PIH group was slightly lower than, but not significantly different from, that of patients in the control group. Prior to receiving RSI, patients in the PIH group had significantly lower systolic blood pressure than those in the control group (124 mmHg vs. 148 mmHg, p ¼ 0.004). The systolic and diastolic blood pressures after RSI were significantly lower in the PIH group than in the control group (70 mmHg vs. 141 mmHg, p < 0.001, Table 1 ). Further analysis indicated that COPD [odds ratio (OR) 3.00, 95% confidence interval (CI) 1.06e8.51, p ¼ 0.05] and sepsis (OR 6.69, 95% CI 2.29e19.47, p < 0.001) were more significant predictors of PIH than were ongoing diseases. The level of albumin in the PIH group, 25 g/L, was markedly lower than that in the control group, 29 g/L ( p ¼ 0.003). Lidocaine as one of the pretreatment medications was found to be associated with PIH (OR 8.13, 95% CI 1.06e62.53, p ¼ 0.02, Table 2 ). Of the 120 patients who received lidocaine injection, 27 developed PIH, whereas one of the 29 patients who did not receive lidocaine developed PIH. However, the dose of lidocaine adjusted for body weight showed no significant differences between groups (Table 1) .
Patients receiving lidocaine were further matched with those who did not receive lidocaine using a propensity score ( Table 3 ). The c-statistic for the propensity score model indicated good decimation (data not shown). After propensity score matching, the lidocaine group became more similar to the group receiving no lidocaine. As indicated in Table 3 , the lidocaine group then had more similar distributions of demographics (e.g., sex), underlying disease (e.g., COPD, CVA, HTN, and malignancy), ongoing diseases (e.g., pneumonia, CVA, sepsis, and intoxication), and pretreatment medication (e.g., rocurorium). However, the matched patients with lidocaine were still statistically different from those with no lidocaine in that they were more likely to be older (73 years vs. 60 years, p ¼ 0.03), and to have ongoing other heart diseases (OR 4.82, p ¼ 0.03). Other variables remained insignificantly different between groups ( Table 4 ).
The traditional regression method was used to adjust preintubation hypotension (SBP < 140 mmHg), underlying COPD history, ongoing septic status, and body weight as confounders (Model 1, Table 5 ). In this multiple logistic regression model, the administration of lidocaine as a pretreatment medication was found to be associated with PIH, although this was not statistically significant (OR 5.51, p ¼ 0.11). In Model 2, the association between administration of lidocaine and PIH were analyzed using propensity score matching of the lidocaine group versus the nonlidocaine group, in which lidocaine administration was statistically significantly associated with PIH (OR 9.33, p ¼ 0.036, Table  5 ). In order to adjust the residual confounding caused by age and ongoing other heart diseases, these statistical models were further established and the fitness of the models examined by AIC (Models 3 and 4, Table 5 ). The association between lidocaine administration and PIH remained statistically significant in these two models (OR: 10.69 and 11.55, p ¼ 0.027 and 0.024, respectively). According to the AIC, the traditional logistical regression model was the least optimal statistical model, and the propensity score matched logistic regression models showed better performance (AIC 126 vs. 71, 73 and 74, respectively).
Discussion
In this study, we illustrated the effect of different statistical models such as traditional logistic regression and propensity score based logistic regression models. We addressed the possible prognostic factors for hypotension after RSI, which included vital signs prior to RSI, ongoing COPD and sepsis, and hypoalbuminemia. In a previous study, 20 we reported that the frequency and dose of lidocaine were higher in the hypotension group than in the control group. However, the relationship between lidocaine administration and PIH remained uncertain after adjustment for body weight. 20 We reanalyzed the same raw data and re-examined the relationship between hypotension after RSI and the use of lidocaine using propensity score matching. The results obtained by using this method provided a different conclusion: that lidocaine as one of the pretreatment medications for RSI might be, in fact, associated with postintubation hypotension.
There are a number of pharmacological and physiological processes underlying the association between lidocaine and postintubation hypotension after RSI. The main effects of lidocaine area decrease in the conductance of sodium channels, antiarrhythmic effects, sedation, and neural blockade. Lidocaine blocks sodium channels through a "fast ineslow out" mechanism that affects impulse conduction through the heart and nerve tissue. This mechanism depresses V max (i.e., the rate of depolarization during Phase 0 of the cardiac action potential) and may lead to re-entrant arrhythmias. Additionally, conduction through the sinus and atrialeventricular nodes may be suppressed. Therefore, the decreases in conduction rate and force of contraction of the heart may contribute to reduced cardiac output, resulting in hypotension.
We identified sepsis as one of the important prognostic factors in PIH, because of the nature of the condition in patients. Maintaining hemodynamic stability in patients with respiratory failure is important due to increased mortality risk. 21 Preintubation hypotension is associated with severe complications and death after airway management. 22 Similarly, PIH during general anesthesia is related to increased mortality. 23 The reduced effective intravascular volumes in patients with sepsis is the primary cause of circulatory instability and collapse. 24 A sudden decrease in sympathetic tone after intubation may cause extreme hemodynamic changes, which further results in hypotension. 25 In COPD, the mechanism is similar. The decrease in sympathetic vascular tone leads to hemodynamic compromise by reducing cardiac parameters of preload and afterload. 11 Positive ventilation and end-expiratory pressure have been found to reduce intrathoracic pressure, which hinders venous return from peripheral circulation to right ventricle. This causes further deterioration of the physiological status of the patients with COPD and can result in profound hypotension. 25 Albumin was another important prognostic factor for PIH. The likely mechanism is that increased capillary membrane permeability causes loss of intravascular colloid osmotic pressure when fluid shifts into the tissues. 26 A previous study indicated 27 that patients with low body weight had higher mortality rates than those with normal weight.
The propensity score matching based method can reduce significant confounding factors. Because of the small sample size in this study, the previous traditional logistic regression method was not strong enough to demonstrate the barely significant effect of lidocaine administration. In this study, we used the propensity score matching method and matched the comparable patients with similar demographics, underlying illnesses, and ongoing illnesses, without sacrificing the power required in the statistical model. Therefore, we hypothesized that the difference in the results between these methods could be because of the statistical power. Another advantage of propensity score matching is that the two-step analysis can avoid bias. We incorporated a broad set of controls for observed confounders and used propensity score analysis, which removes some measured confounders to the extent that they are correlated with the observed covariates.
Limitations of this study include small sample size and the lack of evaluation of the interaction with other RSI agents and ongoing or underlying illness. Better propensity matching is required in future studies. This method cannot be generalized, and thus a single-center study is not sufficient to provide adequate evidence. Immeasurable confounding factors of this study include physician preference and volume status. Posthoc analysis, secondary data analysis, and the fact that the analyst was not blinded to the study were other limitations. An improved study design is required to get better results.
In conclusion, we suggest that lidocaine injection may be associated with PIH in the performance of RSI. Emergency physicians should carefully consider the indication for premedication agents for RSI. In addition, researchers should consider methods other than traditional statistical methods when making causal inference.
